Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, October 10, 2026

Back to today

From X

@majgeoinvesting

Maj Soueidan on X

Just finished going over the $BWEN Q2 earnings script. There might be a glimmer of hope it to keep it interesting in the short term: •Unfortunately, 19% EBITDA industrial segment margins will “fall to more normal levels.” For the last three years, that’s ranged between 11 and 15%. However, revenue will be above historical levels. •Backlog is exceptionally strong, with visibility out to 2028. These guys have never had that kind of visibility. •It looks like a chance for profitability comes from me two scenarios. 1). Aggressively growing the industrial segment because it doesn’t look like margin expansion will occur. 2). The gearing segment EBITDA margins have been historically low, under 10%. So an expansion there, while also getting revenue growth might be interesting. •As far as acquisitions go, I’m not holding out for them finding a great deal. You have to think that valuations will be extended. I would actually prefer them to take their time, by being patient and growing organically - filling some of the available capacity they have right now. •In the end, it’s all about margins for these guys. They really have had a hard time keeping them stable.
@majgeoinvesting

Maj Soueidan on X

$BWEN .. eh...Sales and backlog momo are strong, but still losses. Only watching to see if Co. can reverse a long history of losses, now that it has sold off its volatile wind power assets to $IESC to focus on its power generation equipment & supply chain segments. Interestingly, supply chain segment EBITDA margins were 19%, even though consolidated EBTIDA margins were 6.4%. Stock might actually rip on this KPI. Not quite sure. Do your own homework. Source: @InfoArbMonitor

Investor Letters

All letters

What I’ve Been Up To

Cogent Communications and AI data-center bottlenecks feature in a newsletter update on recruiting, financial media and conference takeaways.

CCOI $430M
Stock Thoughts 2 clicks

Not So Fast

Entravision, the portfolio’s largest position, fell more than 40% from its highs as Q3 returns dropped to 37.8% YTD.

EVC $598M
The Mikro Kap 1 click
BNTC · long

Benitec Biopharma INC

Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.

BNTC $316M
Value Investors Club

Solid Power Still Has Promise

Solid Power reported a $0.11 Q2 loss and $419.3 million of cash, with its electrolyte pilot line and BMW and SK On validation central to…

SLDP $518M
Quad 7 Capital 2 clicks

Zentek Research Note

Zentek shipped its first ZenGUARD air-filter order to a Canadian federal facility as its Albany graphite PEA confirmed a US$3.85 billion…

ZTEKF $58M
Atrium Research - Equity Research 1 click

💥Yield!💥

Beyond Meat’s Q2 2026 revenue fell 8.2% as U.S. retail and foodservice volumes declined, while a flatter, not inverted, Treasury curve…

BYND $132M
PETITION

Updates

FGPR remains on track, PRTH's management buyout is set at $8.05, and microcap RAVE is described as cheap.

FGPR $248MPRTH $644M
Nat Stewart - Stock Picking Newsletter 8 clicks

Is The Bond Market Running On Empty?

U.S. Treasury yields are testing credit and equity markets, while the discussion also targets recent changes at Glass House (GLAS).

GLAS $401M
WHAT ARE WE DOING? “Contrarians At The Gate” 1 click

Publications we follow

Every publication on this site, hand-picked.

128 publications

Newsletters 106

YouTube 4

Blogs 17

Seeking Alpha 46 of 223

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

84 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.